168 related articles for article (PubMed ID: 8653713)
21. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.
Kobayashi M; Kobayashi H; Pollard RB; Suzuki F
J Immunol; 1998 Jun; 160(12):5869-73. PubMed ID: 9637498
[TBL] [Abstract][Full Text] [Related]
22. A flow cytometric assay reveals an enhancement of phagocytosis by platelet activating factor in murine peritoneal macrophages.
Ichinose M; Hara N; Sawada M; Maeno T
Cell Immunol; 1994 Jul; 156(2):508-18. PubMed ID: 8025959
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor.
Melnikova V; Bar-Eli M
Cancer Metastasis Rev; 2007 Dec; 26(3-4):359-71. PubMed ID: 17721743
[TBL] [Abstract][Full Text] [Related]
24. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
Heuer H
Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
[No Abstract] [Full Text] [Related]
25. Effect of blocking TNF on IL-6 levels and metastasis in a B16-BL6 melanoma/mouse model.
Cubillos S; Scallon B; Feldmann M; Taylor P
Anticancer Res; 1997; 17(3C):2207-11. PubMed ID: 9216689
[TBL] [Abstract][Full Text] [Related]
26. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a).
Kawano Y; Furukawa Y; Fukuda J; Matsumoto H; Yuge A; Narahara H
Am J Reprod Immunol; 2007 Nov; 58(5):434-9. PubMed ID: 17922696
[TBL] [Abstract][Full Text] [Related]
27. Effect induced by interleukin-1 on the behaviour of B16F10 melanoma cells.
De Galdeano AG; Boyano D; Cañavate L
Oncol Rep; 1999; 6(1):225-8. PubMed ID: 9864433
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
29. Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.
Grunfeld C; Adi S; Soued M; Moser A; Fiers W; Feingold KR
Cancer Res; 1990 Jul; 50(14):4233-8. PubMed ID: 2364381
[TBL] [Abstract][Full Text] [Related]
30. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
31. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
32. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
Horvath CJ; Kaplan JE; Malik AB
Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
[TBL] [Abstract][Full Text] [Related]
33. [Recombinant tumor necrosis factor promotes the formation of hematogenic metastases to the lungs of C57Bl/6 mice].
Kudriavets IuI; Didkovskaia LP
Eksp Onkol; 1990; 12(2):47-50. PubMed ID: 2318134
[TBL] [Abstract][Full Text] [Related]
34. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
35. Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent.
Chen LW; Huang HL; Lee IT; Hsu CM; Lu PJ
Shock; 2006 Jul; 26(1):69-76. PubMed ID: 16783201
[TBL] [Abstract][Full Text] [Related]
36. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor primes the effects of platelet-activating factor on rat vascular permeability.
Sirois MG; Plante GE; Braquet P; Sirois P
J Lipid Mediat; 1990; 2 Suppl():S109-17. PubMed ID: 2133277
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
[TBL] [Abstract][Full Text] [Related]
39. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
